TISENTO
Live / Applied — First extension granted (statement of use) (as of 21 May 2025)
What this means for you
Not registered yet, but its 07 Jul 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98075581
- Mark type
- Stylized text
- Filed
- 07 Jul 2023
- Published for opposition
- 12 Nov 2024
- Attorney of record
- Anessa Kramer
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of mitochondrial diseases or disorders
- Class 042 — Scientific and technological services: Pharmaceutical research and development; conducting pharmaceutical clinical trials for others in the field of mitochondrial disease; pharmaceutical product development
Owner
- TISENTO THERAPEUTICS INC., Cambridge, MA, US
- TISENTO THERAPEUTICS INC., Cambridge, MA, US
- JW Cycle Inc., Santa Rosa, CA, US
Prosecution history
- 17 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 22 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 May 2025 — SOU EXTENSION 1 GRANTED
- 21 May 2025 — SOU EXTENSION 1 FILED
- 21 May 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Nov 2024 — PUBLISHED FOR OPPOSITION
- 23 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Sept 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Jun 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 26 Jun 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED